<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 3. Effects of Fenofibric Acid Tablets or Fenofibrate Co-Administration on Systemic Exposure of Other Drugs</caption>
<col align="left" valign="top" width="31%"></col>
<col align="left" valign="top" width="32%"></col>
<col align="left" valign="top" width="12%"></col>
<col align="left" valign="top" width="12%"></col>
<col align="left" valign="top" width="13%"></col>
<thead>
<tr>
<th>Dosage Regimen of Fenofibrate</th>
<th>Dosage Regimen of Co-Administered Drug</th>
<th colspan="3">Change in Co-Administered Drug Exposure</th>
</tr>
<tr>
<th></th>
<th></th>
<th>Analyte</th>
<th>AUC</th>
<th>C<sub>max</sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td colspan="5">
<content stylecode="bold">No dosing adjustment required for these co-administered drugs with fenofibric acid tablets</content>
</td>
</tr>
<tr>
<td colspan="5">
<content stylecode="italics">Lipid-lowering agents</content>
</td>
</tr>
<tr>
<td>Fenofibrate<br/> 160 mg<footnote id="t3ft1">TriCor<sup>®</sup> (fenofibrate) oral tablet</footnote> once daily for 10 days</td>
<td>Atorvastatin, 20 mg once daily for 10 days</td>
<td>Atorvastatin</td>
<td>↓17%</td>
<td>0%</td>
</tr>
<tr>
<td>Fenofibrate<br/>3 × 67 mg<footnote id="t3ft2">TriCor<sup>®</sup> (fenofibrate) oral micronized capsule </footnote> as a single dose</td>
<td>Pravastatin, 40 mg as a single dose</td>
<td>Pravastatin</td>
<td>↑13%</td>
<td>↑13%</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3α-Hydroxyl-iso-pravastatin</td>
<td>↑26%</td>
<td>↑29%</td>
</tr>
<tr>
<td>Fenofibrate<br/>160 mg<footnoteref idref="t3ft1"></footnoteref> once daily for 10 days</td>
<td>Pravastatin, 40 mg once daily for 10 days</td>
<td>Pravastatin</td>
<td>↑28%</td>
<td>↑36%</td>
</tr>
<tr>
<td></td>
<td></td>
<td>3α-Hydroxyl-iso-pravastatin</td>
<td>↑39%</td>
<td>↑55%</td>
</tr>
<tr>
<td>Fenofibrate<br/>160 mg<footnoteref idref="t3ft1"></footnoteref> as a single dose</td>
<td>Fluvastatin, 40 mg as a single dose</td>
<td>(+)-3R, 5S-Fluvastatin</td>
<td>↑15%</td>
<td>↑16%</td>
</tr>
<tr>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td colspan="5">
<content stylecode="italics">Anti-diabetic agents</content>
</td>
</tr>
<tr>
<td>Fenofibrate<br/>145 mg<footnoteref idref="t3ft1"></footnoteref> once daily for 10 days</td>
<td>Glimepiride, 1 mg as a single dose</td>
<td>Glimepiride</td>
<td>↑35%</td>
<td>↑18%</td>
</tr>
<tr>
<td>Fenofibrate<br/>54 mg<footnoteref idref="t3ft1"></footnoteref> three times daily for 10 days</td>
<td>Metformin, 850 mg three times daily for 10 days</td>
<td>Metformin</td>
<td>↑3%</td>
<td>↑6%</td>
</tr>
<tr>
<td>Fenofibrate<br/>145 mg<footnoteref idref="t3ft1"></footnoteref> once daily for 14 days</td>
<td>Rosiglitazone, 8 mg once daily for 5 days</td>
<td>Rosiglitazone</td>
<td>↑6%</td>
<td>↓1%</td>
</tr>
<tr>
<td colspan="5">
<content stylecode="italics">Anti-viral agents</content>
</td>
</tr>
<tr>
<td>Fenofibric acid tablets<br/>105 mg once daily for 10 days</td>
<td>Efavirenz, 600 mg as a single dose</td>
<td>Efavirenz</td>
<td>↓8%</td>
<td>↑1%</td>
</tr>
</tbody>
</table>